Roche announced its next generation assay received FDA 510(k) clearance for the measurement of lipoprotein(a) for assessment ...

My cholesterol has been on the rise for the past few years – and not just a slow creep. For most of my life, my LDL (often referred to as ...

Fluctuating LDL and total cholesterol levels in older adults may indicate increased dementia and cognitive decline risk.

Lipoprotein(a) has long been recognized as a critical marker for people at risk of cardiovascular disease. However, the health care industry has lacked the tools to tackle the problem.

In comparison, high-density lipoprotein works to reduce cholesterol levels by absorbing it and carrying it back to the liver.

A new study reveals that high HDL cholesterol may increase glaucoma risk, challenging the notion of it being entirely ...

Approximately one in five people worldwide has elevated Lp(a) levels, putting them at increased risk of cardiovascular diseases including myocardial infarction and stroke. 1 The Roche Diagnostics Tina ...

The test, which is intended for assessing cardiovascular risk, is the first lipoprotein (a), or Lp(a) test measured in nanomoles per liter to receive FDA clearance.